{"id":36946,"date":"2018-03-13T07:00:00","date_gmt":"2018-03-13T05:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&p=36946"},"modified":"2023-09-06T18:13:51","modified_gmt":"2023-09-06T16:13:51","slug":"ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/","title":{"rendered":"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team"},"content":{"rendered":"

Ipsen (Euronext : IPN ; ADR : IPSEY) a annonc\u00e9 aujourd\u2019hui la nomination de deux nouveaux membres au sein de l\u2019Executive Leadership Team. Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., rejoint l\u2019\u00e9quipe en qualit\u00e9 de Vice-Pr\u00e9sident Ex\u00e9cutif, Chief Business Officer, et R\u00e9gis Mulot en qualit\u00e9 de Vice-Pr\u00e9sident Ex\u00e9cutif, Chief Human Resources Officer.
\nDavid Meek, Directeur g\u00e9n\u00e9ral d\u2019Ipsen<\/b>, a comment\u00e9 : \u00ab Je me r\u00e9jouis d\u2019accueillir ces deux leaders reconnus au sein de notre \u00e9quipe de Direction. Ivana et R\u00e9gis joueront tous les deux un r\u00f4le essentiel dans la prochaine phase de transformation d\u2019Ipsen. Ivana dispose de solides r\u00e9f\u00e9rences en mati\u00e8re de Business Development et nous fera profiter de son expertise pour piloter notre strat\u00e9gie d\u2019innovation externe et de partenariats. R\u00e9gis a acquis une solide exp\u00e9rience de Direction de Ressources Humaines au niveau international. Son int\u00e9r\u00eat pour le d\u00e9veloppement des talents et l\u2019innovation au sein des organisations vont nous aider \u00e0 faire avancer notre culture \u00ab One Ipsen \u00bb.<\/em>
\n\u00ab Je tiens \u00e9galement \u00e0 remercier Christophe Jean pour sa contribution importante en tant que Vice-Pr\u00e9sident Ex\u00e9cutif, Strat\u00e9gie et Business Development. Depuis son arriv\u00e9e en 2002, Christophe a jou\u00e9 un r\u00f4le cl\u00e9 pour le d\u00e9veloppement d\u2019Ipsen, et nous lui souhaitons le meilleur pour son d\u00e9part en retraite \u00bb.<\/em>
\nIvana Magov\u010devi\u0107-Liebisch<\/b>, Ph.D., J.D., rejoint Ipsen apr\u00e8s avoir occup\u00e9 le poste de Vice-Pr\u00e9sident Ex\u00e9cutif, Chief Strategy and Corporate Development Officer, au sein d\u2019Axcella Health Inc. Ivana dispose de 20 ann\u00e9es d\u2019exp\u00e9rience \u00e0 des postes de Direction dans l\u2019industrie biopharmaceutique. Elle a acquis une expertise importante, en mati\u00e8re de partenariats, de fusions-acquisitions, de d\u00e9veloppement de pipeline et de portefeuille de produits, mais aussi dans le domaine juridique et de la Propri\u00e9t\u00e9 Intellectuelle.
\nAvant de rejoindre Axcella, le Dr. Magov\u010devi\u0107-Liebisch occupait le poste de Vice-Pr\u00e9sident Senior et Head of Global Business Development au sein de Teva Pharmaceutical Industries Ltd (2013-17), o\u00f9 elle a pilot\u00e9 et mis en \u0153uvre de multiples transactions allant de l\u2019obtention de licences \u00e0 l\u2019acquisition de m\u00e9dicaments candidats, de produits commercialis\u00e9s et d\u2019entreprises pour le secteur de la m\u00e9decine de sp\u00e9cialit\u00e9 au niveau mondial. Avant cela, elle avait occup\u00e9, au sein de Dyax Corp (2001-13), des postes de Direction \u00e0 responsabilit\u00e9s croissantes, notamment en qualit\u00e9 de Vice-Pr\u00e9sident Ex\u00e9cutif et de Chief Operating Officer. Le Dr. Magov\u010devi\u0107-Liebisch a d\u00e9but\u00e9 sa carri\u00e8re dans l\u2019industrie biopharmaceutique au sein de Transkaryotic Therapies Inc. (1998-2001), o\u00f9 elle \u00e9tait Directrice du d\u00e9partement de la propri\u00e9t\u00e9 intellectuelle et des brevets.
\nLe Dr. Magov\u010devi\u0107-Liebisch est membre du Conseil d\u2019Administration d\u2019Applied Genetic Technologies Corporation (AGTC), et de celui d\u2019Alivio Therapeutics, un \u00ab trustee \u00bb de la Suffolk University. Elle exerce \u00e9galement des fonctions de supervision au Boston Ballet, au Boston Museum of Science et au Beth Israel Deaconess Medical Center.
\nLe Dr. Magov\u010devi\u0107-Liebisch est titulaire d\u2019un doctorat (Ph.D.) en g\u00e9n\u00e9tique de l\u2019Universit\u00e9 de Harvard et d\u2019un doctorat (J.D.) en droit des hautes technologies de la Suffolk University Law School. Elle est dipl\u00f4m\u00e9e du Wheaton College avec une licence (B.A.) en biologie et chimie. En 2008, le Dr. Magov\u010devi\u0107-Liebisch a remport\u00e9 le prix \u00ab Women Entrepreneurs in Science and Technology Leadership \u00bb.
\nR\u00e9gis Mulot<\/b> rejoint Ipsen apr\u00e8s avoir occup\u00e9 le poste de Vice-Pr\u00e9sident Ex\u00e9cutif, Chief Human Resources Officer, au sein de Staples Inc., une entreprise mondiale de commerce de d\u00e9tail sp\u00e9cialis\u00e9 et d\u2019e-commerce, o\u00f9 il dirigeait une \u00e9quipe internationale en charge des ressources humaines de plus de 600 collaborateurs. M. Mulot a acquis une exp\u00e9rience solide \u00e0 l\u2019international et des r\u00e9f\u00e9rences reconnues dans la gestion du d\u00e9veloppement des talents, de la planification strat\u00e9gique et de la culture d\u2019entreprise, dans diff\u00e9rents secteurs. Il a dirig\u00e9 des initiatives de changement importantes, en pilotant les Ressources Humaines et l\u2019innovation organisationnelle. Il est fortement attach\u00e9 \u00e0 l\u2019int\u00e9gration et \u00e0 l\u2019engagement des collaborateurs et au d\u00e9veloppement des entreprises gr\u00e2ce aux nouvelles technologies.
\nAvant de rejoindre Staples (2009-18), M. Mulot avait occup\u00e9 des postes de Direction des Ressources Humaines au sein de Levi Strauss & Co (2002-08) et de la start-up technologique Broadnet Europe (2000-02), apr\u00e8s avoir travaill\u00e9 au sein de GTECH Corporation (1994-2000), d\u2019International Post Corporation (1991-94) et de Chronopost SA (1989-91).
\nM. Mulot est membre du \u00ab Board of Trustees \u00bb du Simmons College (Boston, Massachusetts), ancien Pr\u00e9sident du \u00ab Business Advisory Committee \u00bb de la Simmons School of Management (2014-2017), membre de la Chambre de Commerce Franco-Am\u00e9ricaine (Nouvelle-Angleterre), et Fondateur et Pr\u00e9sident du forum RH Franco-Am\u00e9ricain depuis 2016. Il est co-pr\u00e9sident du Boston CHRO (Chief Human Resources Officers) Leadership Summit depuis 2014, et membre du Gartner CHRO Leadership Board depuis 2017.
\nM. Mulot est titulaire d\u2019un DESS en Entreprises Publiques de Paris XI-Sud en partenariat avec Paris IX-Dauphine et l\u2019Institut International d\u2019Administration Publique (IIAP). Il est \u00e9galement titulaire d\u2019une Ma\u00eetrise en Droit Public de Paris II\u2013Panth\u00e9on-Assas, et membre honorifique de la soci\u00e9t\u00e9 Beta Gamma Sigma du Simmons College<\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1233,3556],"tags":[],"class_list":["post-36946","press_release","type-press_release","status-publish","hentry","category-pressrelease-fr","category-corporate-pressrelease-fr","entry"],"acf":[],"yoast_head":"\nIpsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-06T16:13:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\"},\"headline\":\"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team\",\"datePublished\":\"2018-03-13T05:00:00+00:00\",\"dateModified\":\"2023-09-06T16:13:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/\"},\"wordCount\":907,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"articleSection\":[\"Communiqu\u00e9 de presse\",\"Corporate\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/\",\"name\":\"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2018-03-13T05:00:00+00:00\",\"dateModified\":\"2023-09-06T16:13:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/","og_locale":"fr_FR","og_type":"article","og_title":"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team","og_url":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/","og_site_name":"Global","article_modified_time":"2023-09-06T16:13:51+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0"},"headline":"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team","datePublished":"2018-03-13T05:00:00+00:00","dateModified":"2023-09-06T16:13:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/"},"wordCount":907,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","articleSection":["Communiqu\u00e9 de presse","Corporate"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/","url":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/","name":"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2018-03-13T05:00:00+00:00","dateModified":"2023-09-06T16:13:51+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/ZjY0YWViYTAtNDJkOS00NWQ3LTkxNTMtNzM5ODRhNGVmNGM2LTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-nomme-ivana-magovcevic-liebisch-ph-d-j-d-et-regis-mulot-au-sein-de-lexecutive-leadership-team\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Ipsen nomme Ivana Magov\u010devi\u0107-Liebisch, Ph.D., J.D., et R\u00e9gis Mulot au sein de l\u2019Executive Leadership Team"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":2,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36946\/revisions"}],"predecessor-version":[{"id":36949,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36946\/revisions\/36949"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=36946"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=36946"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=36946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}